The Bio-Psycho-Social Dimension in Women's Sexual Desire: 'Argumentum ad novitatem'

Nur Syazwani Roslan, Nik Ruzyanei Nik Jaafar, Hatta Sidi, Najwa Baharudin, Jaya Kumar, Srijit Das, Nik Hazlina Nik Hussain

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Sexual desire includes complex motivation and drive. In the context of biological and cognitive- emotive state art of science, it is often a neglected field in medicine. In regard to the treatment, study on women's sexual function received less attention compared to the men's sexuality. In the past, this endeavor was relatively not well disseminated in the scientific community. Recently, there was a revolutionized surge of drug targets available to treat women with low sexual desire. It is timely to review the relevant biological approach, especially in the context of pharmacotherapy to understand this interesting clinical entity which was modulated by numerous interactive psychosocial inter-play and factors. The complex inter-play between numerous dimensional factors lends insights to understand the neural mechanism, i.e. the rewards centre pathway and its interaction with external psychosocialstimulus, e.g. relationship or other meaningful life events. The function of hormones, e.g. oxytocin or testosterone regulation was described. The role of neurotransmitters as reflected by the introduction of a molecule of flibenserin, a full agonist of the 5-HT1A and partial agonist of the D4 to treat premenopausal women with low sexual desire was deliberated. Based on this fundamental scientific core knowledge, we suggest an outline on know-how of introduction for sex therapy (i.e. "inner-self" and "outer-self") where the role of partner is narrated. Then, we also highlighted on the use of pharmacological agent as an adjunct scope of therapy, i.e. phosphodiasterase-5 (PDE-5) inhibitors and hormonal treatment in helping the patient with low sexual desire.

Original languageEnglish
Pages (from-to)146-157
Number of pages12
JournalCurrent Drug Targets
Volume20
Issue number2
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Serotonin 5-HT1 Receptor Agonists
Drug therapy
Oxytocin
Medicine
Neurotransmitter Agents
Testosterone
Hormones
Molecules
Sexuality
Therapeutics
Art
Reward
Pharmaceutical Preparations
Motivation
Pharmacology
Drug Therapy
Drive

Keywords

  • Female sexual desire
  • flibanserin
  • low sexual desire
  • neural basis
  • PDE-5 inhibitor
  • psychosocial dimension.

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

The Bio-Psycho-Social Dimension in Women's Sexual Desire : 'Argumentum ad novitatem'. / Roslan, Nur Syazwani; Nik Jaafar, Nik Ruzyanei; Sidi, Hatta; Baharudin, Najwa; Kumar, Jaya; Das, Srijit; Hussain, Nik Hazlina Nik.

In: Current Drug Targets, Vol. 20, No. 2, 01.01.2019, p. 146-157.

Research output: Contribution to journalArticle

Roslan, Nur Syazwani ; Nik Jaafar, Nik Ruzyanei ; Sidi, Hatta ; Baharudin, Najwa ; Kumar, Jaya ; Das, Srijit ; Hussain, Nik Hazlina Nik. / The Bio-Psycho-Social Dimension in Women's Sexual Desire : 'Argumentum ad novitatem'. In: Current Drug Targets. 2019 ; Vol. 20, No. 2. pp. 146-157.
@article{0392e08ae4a54e3f980d48ab7ff6773c,
title = "The Bio-Psycho-Social Dimension in Women's Sexual Desire: 'Argumentum ad novitatem'",
abstract = "Sexual desire includes complex motivation and drive. In the context of biological and cognitive- emotive state art of science, it is often a neglected field in medicine. In regard to the treatment, study on women's sexual function received less attention compared to the men's sexuality. In the past, this endeavor was relatively not well disseminated in the scientific community. Recently, there was a revolutionized surge of drug targets available to treat women with low sexual desire. It is timely to review the relevant biological approach, especially in the context of pharmacotherapy to understand this interesting clinical entity which was modulated by numerous interactive psychosocial inter-play and factors. The complex inter-play between numerous dimensional factors lends insights to understand the neural mechanism, i.e. the rewards centre pathway and its interaction with external psychosocialstimulus, e.g. relationship or other meaningful life events. The function of hormones, e.g. oxytocin or testosterone regulation was described. The role of neurotransmitters as reflected by the introduction of a molecule of flibenserin, a full agonist of the 5-HT1A and partial agonist of the D4 to treat premenopausal women with low sexual desire was deliberated. Based on this fundamental scientific core knowledge, we suggest an outline on know-how of introduction for sex therapy (i.e. {"}inner-self{"} and {"}outer-self{"}) where the role of partner is narrated. Then, we also highlighted on the use of pharmacological agent as an adjunct scope of therapy, i.e. phosphodiasterase-5 (PDE-5) inhibitors and hormonal treatment in helping the patient with low sexual desire.",
keywords = "Female sexual desire, flibanserin, low sexual desire, neural basis, PDE-5 inhibitor, psychosocial dimension.",
author = "Roslan, {Nur Syazwani} and {Nik Jaafar}, {Nik Ruzyanei} and Hatta Sidi and Najwa Baharudin and Jaya Kumar and Srijit Das and Hussain, {Nik Hazlina Nik}",
year = "2019",
month = "1",
day = "1",
doi = "10.2174/1389450118666170622090337",
language = "English",
volume = "20",
pages = "146--157",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - The Bio-Psycho-Social Dimension in Women's Sexual Desire

T2 - 'Argumentum ad novitatem'

AU - Roslan, Nur Syazwani

AU - Nik Jaafar, Nik Ruzyanei

AU - Sidi, Hatta

AU - Baharudin, Najwa

AU - Kumar, Jaya

AU - Das, Srijit

AU - Hussain, Nik Hazlina Nik

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Sexual desire includes complex motivation and drive. In the context of biological and cognitive- emotive state art of science, it is often a neglected field in medicine. In regard to the treatment, study on women's sexual function received less attention compared to the men's sexuality. In the past, this endeavor was relatively not well disseminated in the scientific community. Recently, there was a revolutionized surge of drug targets available to treat women with low sexual desire. It is timely to review the relevant biological approach, especially in the context of pharmacotherapy to understand this interesting clinical entity which was modulated by numerous interactive psychosocial inter-play and factors. The complex inter-play between numerous dimensional factors lends insights to understand the neural mechanism, i.e. the rewards centre pathway and its interaction with external psychosocialstimulus, e.g. relationship or other meaningful life events. The function of hormones, e.g. oxytocin or testosterone regulation was described. The role of neurotransmitters as reflected by the introduction of a molecule of flibenserin, a full agonist of the 5-HT1A and partial agonist of the D4 to treat premenopausal women with low sexual desire was deliberated. Based on this fundamental scientific core knowledge, we suggest an outline on know-how of introduction for sex therapy (i.e. "inner-self" and "outer-self") where the role of partner is narrated. Then, we also highlighted on the use of pharmacological agent as an adjunct scope of therapy, i.e. phosphodiasterase-5 (PDE-5) inhibitors and hormonal treatment in helping the patient with low sexual desire.

AB - Sexual desire includes complex motivation and drive. In the context of biological and cognitive- emotive state art of science, it is often a neglected field in medicine. In regard to the treatment, study on women's sexual function received less attention compared to the men's sexuality. In the past, this endeavor was relatively not well disseminated in the scientific community. Recently, there was a revolutionized surge of drug targets available to treat women with low sexual desire. It is timely to review the relevant biological approach, especially in the context of pharmacotherapy to understand this interesting clinical entity which was modulated by numerous interactive psychosocial inter-play and factors. The complex inter-play between numerous dimensional factors lends insights to understand the neural mechanism, i.e. the rewards centre pathway and its interaction with external psychosocialstimulus, e.g. relationship or other meaningful life events. The function of hormones, e.g. oxytocin or testosterone regulation was described. The role of neurotransmitters as reflected by the introduction of a molecule of flibenserin, a full agonist of the 5-HT1A and partial agonist of the D4 to treat premenopausal women with low sexual desire was deliberated. Based on this fundamental scientific core knowledge, we suggest an outline on know-how of introduction for sex therapy (i.e. "inner-self" and "outer-self") where the role of partner is narrated. Then, we also highlighted on the use of pharmacological agent as an adjunct scope of therapy, i.e. phosphodiasterase-5 (PDE-5) inhibitors and hormonal treatment in helping the patient with low sexual desire.

KW - Female sexual desire

KW - flibanserin

KW - low sexual desire

KW - neural basis

KW - PDE-5 inhibitor

KW - psychosocial dimension.

UR - http://www.scopus.com/inward/record.url?scp=85060042676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060042676&partnerID=8YFLogxK

U2 - 10.2174/1389450118666170622090337

DO - 10.2174/1389450118666170622090337

M3 - Article

C2 - 28641524

AN - SCOPUS:85060042676

VL - 20

SP - 146

EP - 157

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 2

ER -